RediNews
ETFs Holding PBE »    PBE Historical Stock Prices »
PBE News Video: Fri, Jun 2, 2017, 11:00 AM — SDS, PBE: Big ETF Inflows


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
PowerShares WilderHill Progressive Energy is an open-end management investment company. The fund generally will invest at least 90% of its total assets in common stocks of companies engaged principally in the progressive energy business that comprise the underlying index. The underlying index was composed of common stocks that are publicly traded in the United States and engaged in a business or businesses that the index provider may benefit from a societal shift toward the transitional energy technologies. As of Apr 30 2013, the Fund's total assets were $38,686,290 and the Fund's investments portfolio was valued at $38,640,453. Self directed investors in PowerShares Exchange- Traded Fund Trust- WilderHill Progressive Energy Ptf will be interested in keeping up with all PowerShares Exchange- Traded Fund Trust- WilderHill Progressive Energy Ptf news they can find, both PBE news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on PBE. At RediNews, we simplify this task by presenting both PBE news releases originating from PowerShares Exchange- Traded Fund Trust- WilderHill Progressive Energy Ptf itself, and PBE news from a variety of media outlets. Visitors can browse this news online and through our PBE RSS news feed.

PBE News

PBE News — Articles, Videos, & Press Releases

Oversold Conditions For Repligen
Monday, February 5, 2018, 12:07 PM — Dividend Channel
Add Up The Pieces: PBE Could Be Worth $57
Monday, February 5, 2018, 9:55 AM — ETF Channel
ALXN Makes Notable Cross Below Critical Moving Average
Tuesday, January 30, 2018, 11:54 AM — Market News Video
OPKO Health is Now Oversold (OPK)
Thursday, January 18, 2018, 1:12 PM — Dividend Channel
M&A Waves Pushing Biotech ETFs Higher
Thursday, January 18, 2018, 9:15 AM — Zacks
Surprising Analyst 12-Month Target For PBE
Thursday, January 18, 2018, 8:30 AM — ETF Channel
MNTA Makes Bullish Cross Above Critical Moving Average
Friday, January 5, 2018, 11:47 AM — Market News Video
Sum Up The Parts: PBE Could Be Worth $55
Friday, January 5, 2018, 9:11 AM — ETF Channel
GHDX Crosses Above Key Moving Average Level
Thursday, December 14, 2017, 11:42 AM — Market News Video
Oversold Conditions For Genomic Health (GHDX)
Wednesday, December 13, 2017, 12:07 PM — Dividend Channel
ACOR Crosses Above Key Moving Average Level
Wednesday, December 13, 2017, 11:41 AM — Market News Video
Analysts Predict 22% Upside For PBE
Thursday, December 7, 2017, 8:20 AM — ETF Channel
Top Buys by Directors: Lema's $163.4K Bet on FGEN
Wednesday, December 6, 2017, 3:55 PM — Dividend Channel
FibroGen is Now Oversold (FGEN)
Monday, December 4, 2017, 4:36 PM — Dividend Channel
United Therapeutics (UTHR) Shares Cross Above 200 DMA
Wednesday, November 29, 2017, 4:04 PM — Market News Video
Relative Strength Alert For Vanda Pharmaceuticals
Friday, November 17, 2017, 4:21 PM — Dividend Channel
PowerShares Dynamic Biotechnology & Genome Portfolio Getting Very Oversold
Friday, November 17, 2017, 10:48 AM — ETF Channel
Implied PBE Analyst Target Price: $57
Thursday, November 16, 2017, 9:27 AM — ETF Channel
Oversold Conditions For Acorda Therapeutics (ACOR)
Wednesday, November 15, 2017, 11:57 AM — Dividend Channel
Biotech ETFs: What Lies Ahead?
Monday, November 13, 2017, 4:18 PM — Zacks
Relative Strength Alert For FibroGen
Friday, November 10, 2017, 4:24 PM — Dividend Channel
Relative Strength Alert For Genomic Health
Friday, November 10, 2017, 11:52 AM — Dividend Channel
RSI Alert: Repligen (RGEN) Now Oversold
Thursday, November 9, 2017, 12:03 PM — Dividend Channel
Akebia Therapeutics Enters Oversold Territory (AKBA)
Thursday, November 9, 2017, 11:58 AM — Dividend Channel
GHDX Crosses Below Key Moving Average Level
Tuesday, November 7, 2017, 4:51 PM — Market News Video
Peek Under The Hood: PBE Has 21% Upside
Monday, November 6, 2017, 9:29 AM — ETF Channel
Epizyme Enters Oversold Territory (EPZM)
Thursday, November 2, 2017, 12:05 PM — Dividend Channel
RSI Alert: Myriad Genetics (MYGN) Now Oversold
Thursday, November 2, 2017, 12:00 PM — Dividend Channel
Epizyme Breaks Below 200-Day Moving Average - Notable for EPZM
Thursday, November 2, 2017, 11:53 AM — Market News Video
Investors Land EPZM 21.6% Cheaper Than Its Secondary Stock Offering
Thursday, November 2, 2017, 10:03 AM — Dividend Channel
Oversold Conditions For Alexion Pharmaceuticals (ALXN)
Thursday, October 26, 2017, 11:59 AM — Dividend Channel
Vanda Pharmaceuticals Enters Oversold Territory (VNDA)
Thursday, October 26, 2017, 11:58 AM — Dividend Channel
Insys Therapeutics is Now Oversold (INSY)
Thursday, October 26, 2017, 11:58 AM — Dividend Channel
Vanda Pharmaceuticals (VNDA) Shares Cross Below 200 DMA
Thursday, October 26, 2017, 11:47 AM — Market News Video
Notable Two Hundred Day Moving Average Cross - CYTK
Wednesday, October 25, 2017, 12:22 PM — Market News Video
RSI Alert: Vertex Pharmaceuticals (VRTX) Now Oversold
Wednesday, October 25, 2017, 12:09 PM — Dividend Channel
Oversold Conditions For Cytokinetics (CYTK)
Tuesday, October 24, 2017, 4:24 PM — Dividend Channel
Analysts See 17% Gains Ahead For PBE
Tuesday, October 24, 2017, 9:12 AM — ETF Channel
Xencor is Now Oversold (XNCR)
Monday, October 23, 2017, 12:08 PM — Dividend Channel
Esperion Therapeutics Becomes Oversold (ESPR)
Monday, October 23, 2017, 12:08 PM — Dividend Channel
RGEN Crosses Above Key Moving Average Level
Friday, October 20, 2017, 11:40 AM — Market News Video
Relative Strength Alert For MyoKardia
Wednesday, October 18, 2017, 4:35 PM — Dividend Channel
PBE's Underlying Holdings Imply 14% Gain Potential
Monday, October 16, 2017, 10:03 AM — ETF Channel
Add Up The Parts: PBE Could Be Worth $56
Thursday, October 5, 2017, 9:27 AM — ETF Channel
Notable Two Hundred Day Moving Average Cross - MNTA
Wednesday, October 4, 2017, 11:36 AM — Market News Video
Notable Two Hundred Day Moving Average Cross - RGEN
Tuesday, September 26, 2017, 5:51 PM — Market News Video
Relative Strength Alert For Repligen
Tuesday, September 26, 2017, 12:05 PM — Dividend Channel
How The Parts Add Up: PBE Targets $56
Friday, September 22, 2017, 8:12 AM — ETF Channel
Top Buys by Directors: Mott's $3M Bet on EPZM
Tuesday, September 19, 2017, 11:09 AM — Dividend Channel
CSII Crosses Below Key Moving Average Level
Monday, September 18, 2017, 4:41 PM — Market News Video
Analysts See 12% Gains Ahead For The Holdings of PBE
Thursday, September 7, 2017, 9:32 AM — ETF Channel
Alkermes is Now Oversold (ALKS)
Tuesday, September 5, 2017, 12:07 PM — Dividend Channel
GHDX Crosses Above Key Moving Average Level
Tuesday, August 29, 2017, 4:26 PM — Market News Video
Biotech ETFs Soar on Gilead-Kite Deal
Tuesday, August 29, 2017, 10:44 AM — Zacks
Notable Two Hundred Day Moving Average Cross - CSII
Friday, August 25, 2017, 4:30 PM — Market News Video
Analysts Forecast 22% Gains Ahead For PBE
Tuesday, August 22, 2017, 9:41 AM — ETF Channel
Top Buys by Directors: Henderson's $111.9K Bet on MYGN
Friday, August 18, 2017, 3:05 PM — Dividend Channel
Investors Grab FGEN Even Lower Than Its Secondary Stock Offering
Thursday, August 17, 2017, 10:07 AM — Dividend Channel
Investors Pick Up ESPR Even Lower Than Its Secondary Stock Offering
Friday, August 11, 2017, 10:07 AM — Dividend Channel
IONS Crosses Below Key Moving Average Level
Thursday, August 10, 2017, 4:46 PM — Market News Video
Alkermes Enters Oversold Territory (ALKS)
Tuesday, August 8, 2017, 4:22 PM — Dividend Channel
Investors Land CYTK 13.3% Cheaper Than Its Secondary Stock Offering
Tuesday, August 8, 2017, 1:29 PM — Dividend Channel
Oversold Conditions For Catalent (CTLT)
Thursday, August 3, 2017, 11:58 AM — Dividend Channel
Qiagen Enters Oversold Territory (QGEN)
Thursday, August 3, 2017, 11:58 AM — Dividend Channel
Genomic Health (GHDX) Shares Cross Below 200 DMA
Wednesday, August 2, 2017, 11:52 AM — Market News Video
Analysts Forecast 13% Upside For PBE
Monday, July 31, 2017, 10:03 AM — ETF Channel
Insys Therapeutics Shares Cross Below 200 DMA
Friday, July 28, 2017, 11:51 AM — Market News Video
ALKS Crosses Below Key Moving Average Level
Thursday, July 27, 2017, 11:46 AM — Market News Video
How The Parts Add Up: PBE Targets $51
Monday, July 17, 2017, 8:53 AM — ETF Channel
Xencor Breaks Above 200-Day Moving Average - Bullish for XNCR
Thursday, July 13, 2017, 4:42 PM — Market News Video
Cytokinetics is Now Oversold (CYTK)
Thursday, June 29, 2017, 4:23 PM — Dividend Channel
Investors Snag RGEN Even Cheaper Than Its Secondary Stock Offering
Thursday, June 29, 2017, 10:32 AM — Dividend Channel
PBE's Underlying Holdings Imply 12% Gain Potential
Wednesday, June 28, 2017, 8:44 AM — ETF Channel
Bullish Two Hundred Day Moving Average Cross - ALXN
Wednesday, June 21, 2017, 4:33 PM — Market News Video
Top Buys by Top Brass: CEO Cohen's $339K Bet on ACOR
Wednesday, June 21, 2017, 10:31 AM — Dividend Channel
Top Buys by Top Brass: CEO Motahari's $113.9K Bet on INSY
Thursday, June 15, 2017, 2:37 PM — Dividend Channel
The Math Shows PBE Can Go To $51
Tuesday, June 13, 2017, 9:18 AM — ETF Channel
Noteworthy ETF Outflows: PBE, QGEN, IONS, ALXN
Friday, June 9, 2017, 10:47 AM — ETF Channel
Bargain Hunters Take Note: Insider Cluster-Buying At INSY
Monday, June 5, 2017, 10:58 AM — Dividend Channel
Oversold Conditions For Insmed (INSM)
Wednesday, May 31, 2017, 12:01 PM — Dividend Channel
Progenics Pharmaceuticals Enters Oversold Territory (PGNX)
Wednesday, May 31, 2017, 12:01 PM — Dividend Channel
ZIOPHARM Oncology Enters Oversold Territory (ZIOP)
Wednesday, May 31, 2017, 12:00 PM — Dividend Channel
PBE Crosses Below Key Moving Average Level
Wednesday, May 31, 2017, 10:52 AM — ETF Channel
Oversold Conditions For Lexicon Pharmaceuticals (LXRX)
Tuesday, May 30, 2017, 12:02 PM — Dividend Channel
Oversold Conditions For ANI Pharmaceuticals (ANIP)
Tuesday, May 30, 2017, 12:01 PM — Dividend Channel
Oversold Conditions For Acorda Therapeutics (ACOR)
Thursday, May 25, 2017, 4:24 PM — Dividend Channel
Alexion Pharmaceuticals is Now Oversold (ALXN)
Tuesday, May 23, 2017, 12:07 PM — Dividend Channel
EBS Crosses Below Key Moving Average Level
Monday, May 22, 2017, 12:07 PM — Market News Video
Relative Strength Alert For OPKO Health
Tuesday, May 16, 2017, 4:28 PM — Dividend Channel
BioMarin Pharmaceutical Breaks Below 200-Day Moving Average - Notable for BMRN
Wednesday, May 10, 2017, 11:28 AM — Market News Video
Bag This Bargain Even Cheaper Than Chief Financial Officer Robb Did
Tuesday, May 9, 2017, 10:02 AM — Dividend Channel
Incyte Enters Oversold Territory (INCY)
Monday, May 8, 2017, 12:01 PM — Dividend Channel
Analysts Forecast 25% Upside For PBE
Monday, May 8, 2017, 8:58 AM — ETF Channel
Relative Strength Alert For Progenics Pharmaceuticals
Thursday, May 4, 2017, 11:57 AM — Dividend Channel
Array BioPharma Breaks Below 200-Day Moving Average - Notable for ARRY
Tuesday, May 2, 2017, 4:41 PM — Market News Video
ALXN Makes Bullish Cross Above Critical Moving Average
Thursday, April 27, 2017, 4:21 PM — Market News Video
PBE's Holdings Could Mean 23% Gain Potential
Thursday, April 27, 2017, 9:21 AM — ETF Channel
Bullish Two Hundred Day Moving Average Cross - LXRX
Wednesday, April 26, 2017, 11:35 AM — Market News Video
EBS Crosses Above Key Moving Average Level
Tuesday, April 25, 2017, 4:15 PM — Market News Video
Momenta Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for MNTA
Tuesday, April 25, 2017, 1:24 PM — Market News Video
PGNX Crosses Below Key Moving Average Level
Friday, April 21, 2017, 4:28 PM — Market News Video
Array BioPharma Enters Oversold Territory (ARRY)
Friday, April 21, 2017, 4:26 PM — Dividend Channel
INCY Trading Below Director's Recent Buy Price
Wednesday, April 12, 2017, 10:12 AM — Dividend Channel
Notable Two Hundred Day Moving Average Cross - PBE
Thursday, April 6, 2017, 10:55 AM — ETF Channel
Acorda Therapeutics (ACOR) Shares Cross Below 200 DMA
Friday, March 31, 2017, 4:39 PM — Market News Video
Oversold Conditions For Momenta Pharmaceuticals (MNTA)
Thursday, March 30, 2017, 4:35 PM — Dividend Channel
Trumpcare Collapse Fuels Rally in Healthcare Stocks & ETFs
Tuesday, March 28, 2017, 8:04 AM — Zacks
Add Up The Pieces: PBE Could Be Worth $53
Wednesday, March 22, 2017, 8:31 AM — ETF Channel
Notable Two Hundred Day Moving Average Cross - MNTA
Tuesday, March 21, 2017, 4:51 PM — Market News Video
Alexion Pharmaceuticals Enters Oversold Territory (ALXN)
Tuesday, March 21, 2017, 12:18 PM — Dividend Channel
ZIOPHARM Oncology Breaks Below 200-Day Moving Average - Notable for ZIOP
Tuesday, March 21, 2017, 11:54 AM — Market News Video
BioMarin Pharmaceutical (BMRN) Shares Cross Below 200 DMA
Tuesday, March 21, 2017, 11:52 AM — Market News Video
Implied PBE Analyst Target Price: $52
Tuesday, March 14, 2017, 9:20 AM — ETF Channel
Lexicon Pharmaceuticals (LXRX) Shares Cross Below 200 DMA
Monday, March 13, 2017, 4:31 PM — Market News Video
Time to Buy Biotech ETFs?
Monday, March 13, 2017, 3:46 PM — Zacks
ALXN Crosses Below Key Moving Average Level
Wednesday, March 8, 2017, 4:53 PM — Market News Video
SCMP Crosses Above Key Moving Average Level
Wednesday, March 8, 2017, 11:44 AM — Market News Video
Add Up The Parts: PBE Could Be Worth $52
Monday, March 6, 2017, 8:22 AM — ETF Channel
Trump's Immigration Plans an Overhang on Biotech ETFs?
Thursday, March 2, 2017, 1:00 PM — Zacks
OPKO Health Becomes Oversold (OPK)
Thursday, March 2, 2017, 12:06 PM — Dividend Channel
VRTX Makes Bullish Cross Above Critical Moving Average
Monday, February 27, 2017, 4:46 PM — Market News Video
BioMarin Pharmaceutical Breaks Below 200-Day Moving Average - Notable for BMRN
Friday, February 24, 2017, 11:42 AM — Market News Video
The Math Shows PBE Can Go To $52
Friday, February 24, 2017, 9:38 AM — ETF Channel
Momenta Pharmaceuticals Enters Oversold Territory
Thursday, February 23, 2017, 1:03 PM — Dividend Channel
VNDA Crosses Below Key Moving Average Level
Thursday, February 23, 2017, 11:56 AM — Market News Video
Insys Therapeutics Shares Cross Above 200 DMA
Wednesday, February 22, 2017, 4:34 PM — Market News Video
ANI Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ANIP
Wednesday, February 22, 2017, 11:39 AM — Market News Video
We Did The Math PBE Can Go To $52
Thursday, February 16, 2017, 8:27 AM — ETF Channel
What Lies Ahead for Biotech ETFs in Trump Era?
Friday, January 27, 2017, 3:30 PM — Zacks
Trump Attacks Biotech & Pharma: ETFs Bleed
Thursday, January 12, 2017, 9:08 AM — Zacks
Biotech ETFs Slumping on Q3 Results
Tuesday, November 8, 2016, 2:26 PM — Zacks
4 Frightful ETFs of This Year
Thursday, October 27, 2016, 10:19 AM — Zacks
Inside the Recent Surge in Biotech ETFs
Wednesday, September 14, 2016, 12:19 PM — Zacks
Biotech ETF Industry Outlook
Wednesday, August 31, 2016, 1:39 PM — Zacks
Top and Flop Sector ETFs YTD
Tuesday, July 5, 2016, 8:53 AM — Zacks
Top and Flop ETFs of 1H
Thursday, June 30, 2016, 9:28 AM — Zacks
Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
Tuesday, May 17, 2016, 9:40 AM — Zacks
What Lies Ahead for Biotech ETFs?
Friday, May 13, 2016, 2:48 PM — Zacks
Biotech ETFs Sink on Mixed Q1 Results
Monday, May 2, 2016, 1:22 PM — Zacks
Biotech ETFs Slide as Stocks Report Mixed Q4 Results
Tuesday, February 9, 2016, 12:48 PM — Zacks
What Lies Ahead for Biotech ETFs in 2016?
Friday, January 8, 2016, 4:55 PM — Zacks
Halloween Effect: ETFs That Would Not Scare You
Wednesday, October 28, 2015, 11:36 AM — Zacks
The Comprehensive Guide to Biotech ETFs
Wednesday, September 16, 2015, 9:42 AM — Zacks
The Complete Guide to Biotech ETFs - ETF News And Commentary
Thursday, October 2, 2014, 10:09 AM — Zacks
Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Wednesday, June 25, 2014, 12:00 PM — Zacks
Top Ranked Healthcare ETF in Focus: XPH - ETF News And Commentary
Wednesday, February 12, 2014, 7:01 AM — Zacks
The Guide to Surging Biotech ETFs - ETF News And Commentary
Tuesday, February 11, 2014, 11:00 AM — Zacks
PBE is categorized under the Financials sector; below are links to news for some other companies in the same sector:

PTF News
PSCU News
DLR News
ICF News
RLI News
KME News
TSH News
LIT News
EWZ News
SDY News

Suppose you have experience with web publishing content and are starting a new financial website. You will have a stock index table with every major stock index you can think of, at the top you have the current market time and whether the markets are open or closed, and then you have a quote box where users can enter symbols to get a detailed quote like you would see on an investor relations quote page, along with historical stock quote information either in a stock table or stock market chart graphics. As you design your site, you may have a stock template created once and used for each possible stock ticker symbol, and you may have a stock price panel along the right-hand or left-hand column of other pages of your site. You've got mainly all your basis covered in terms of data, securing a stock market content provider for licensed quote content and historical stock data. But what about news? The same investor relations services providers that provide investor relations content can provide press releases but none of these investor relations tools contain third party articles. While third party articles can sometimes be critical of companies, that's what you want when looking for financial portal content, because corporate relations content designed for investor relations quotes pages is concerned with eliminating negativity and controversy. But third party news articles are critical for websites whose readers want to read all the news about the stocks they own, both published by the company and published by third parties. It is for this reason that RSS feeds by RediNews can add a compelling piece of additional dynamic content to your website. Look for the RSS icon on any news page within RediNews (which will look like this): to access our free RSS-based news feeds to supplement your web content.

PBE News | www.RediNews.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.